Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications clinical unmet needs burden fragile x syndrome results targeted literature review
Webinar: Economic Modelling Challenges in Rare Diseases Share on: Wednesday, February 27, 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data available …
… Health Services Research, Medical Care Research & Review, BMJ Quality & Safety, American Journal of Managed …
… Risk Management group at RTI-HS. She has experience as a clinical research coordinator and project manager for a variety of large clinical and epidemiologic research projects, both … her with practical knowledge of quality assurance, clinical intervention studies, and disease management …
… and drive efficiencies. He also has several academic publications to his name. …
… in the field of pharmacoepidemiology. His experience and publications span a wide range of substantive areas, … has experience with epidemiologic methods, lecturing to clinical and public health audiences about observational …
… disease algorithms and outcome validation in a number of clinical and therapeutic areas. She also has experience with …
… recent position as the project manager for a phase 2/3 clinical trial evaluating the effectiveness of the study drug …
… private sectors and has served as a member of an Evidence Review Group for NICE in the UK. He has worked in therapeutic …
ESMO Congress 2023 Share on: Friday, October 20 - Tuesday, October 24, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the ESMO Congress 2023. Breast cancer specific survival (BCSS) in HR+/HER2- metastatic …
2024 ISPE Annual Meeting Share on: Saturday, August 24 - Wednesday, August 28, 2024 Conference website Celebrating 40 Years of Advancing Pharmacoepidemiology We are pleased to be a gold sponsor of ISPE 2024. Our team will also be attending, speaking, and …